HRB announces winner of special award at BTYSTE
This year, the honour went to the creators of Specs – A Wearable Smart Device for Dementia Patients.
EU4Health: 2022 work programme now published
The EU's new public health funding programme for the year ahead offers a budget of €835m to help improve healthcare systems and patient outcomes.
HRB publishes 'Outputs, outcomes, and emerging
The report reviews awards completed in 2018 and 2019.
HRB invests €21 million in cancer clinical trials
The funding will tackle childhood and adult cancers, making a real difference to the lives of cancer patients.
Health Research in Action
Highlights of the many notable impacts and outcomes of the Health Research Board’s work during 2020 across health and social care in Ireland.
HRB invests €22 million in clinical research infrastructure
The funding will further enhance patient-focused clinical research and trials in Ireland.
HRB supports National Irish COVID-19 Biobank
€2 million investment in the National Irish COVID-19 Biobank will advance high impact research into COVID-19.
HRB reports rise in cocaine and crack cocaine treatment
The latest figures from the Health Research Board (HRB) show continued growth in the number of cases seeking treatment for problem cocaine use, including crack cocaine use, despite an overall drop in the numbers entering drug treatment.
New HRB report examines drug use in Ireland
Report shares main findings of the 2019–20 National Drug and Alcohol Survey and presents trends on what drugs people are using and how often, perceptions and attitudes towards drugs, the impact of drugs on local communities, and more.
HRB publishes latest data on disability services
A total of 36,649 people use or still need a disability service in Ireland according to the latest figures recorded on our National Ability Supports System (NASS).